288 related articles for article (PubMed ID: 24071014)
1. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
2. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
3. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors.
Merchant SH; VanderJagt T; Lathrop S; Amin MB
Am J Surg Pathol; 2006 Dec; 30(12):1581-7. PubMed ID: 17122515
[TBL] [Abstract][Full Text] [Related]
4. [Changes in Helicobacter pylori gastritis caused by therapy with inhibitors of gastric acid secretion].
Stolte M; Meining A
Z Gastroenterol; 1999 Oct; 37(10):1029-36. PubMed ID: 10549099
[TBL] [Abstract][Full Text] [Related]
5. The effect of proton pump inhibitors on the gastric mucosal microenvironment.
Peng YC; Huang LR; Ho HC; Chang CS; Lee SW; Cheng CC; Wen MC; Yeh HZ; Ho SP
Adv Clin Exp Med; 2017; 26(1):39-43. PubMed ID: 28397430
[TBL] [Abstract][Full Text] [Related]
6. Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use.
Miyamoto S; Kato M; Tsuda M; Matsuda K; Muranaka T; Abiko S; Ono M; Mizushima T; Omori S; Yamamoto K; Mabe K; Ono S; Kudo T; Shimizu Y; Sakamoto N
Dig Endosc; 2017 May; 29(3):307-313. PubMed ID: 27859804
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection.
Hahn M; Fennerty MB; Corless CL; Magaret N; Lieberman DA; Faigel DO
Gastrointest Endosc; 2000 Jul; 52(1):20-6. PubMed ID: 10882957
[TBL] [Abstract][Full Text] [Related]
8. Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis.
Yeo M; Kim DK; Han SU; Lee JE; Kim YB; Cho YK; Kim JH; Cho SW; Hahm KB
Gut; 2006 Jan; 55(1):26-33. PubMed ID: 16127019
[TBL] [Abstract][Full Text] [Related]
9. Fundic gland polyps and proton pump inhibitors: an obvious link, or an open question?
Declich P; Belloni J; Tavani E; Omazzi B; Bortoli A; Devani M; Arena I; Bellone S; Saibeni S; Prada A
Hum Pathol; 2014 May; 45(5):1122-3. PubMed ID: 24560019
[No Abstract] [Full Text] [Related]
10. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find.
Genta RM; Lash RH
Am J Surg Pathol; 2010 Aug; 34(8):e25-34. PubMed ID: 20631607
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of invasive gastric Helicobacter pylori.
Dudley J; Wieczorek T; Selig M; Cheung H; Shen J; Odze R; Deshpande V; Zukerberg L
Hum Pathol; 2017 Mar; 61():19-25. PubMed ID: 27771376
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
13. Mucopeptic cell expansion in gastric foveolar epitheleum in Helicobacter pylori-positive, body-fundic chronic superficial gastritis.
Testino G; Cheli R; Cornaggia M
Am J Gastroenterol; 1995 Feb; 90(2):332-3. PubMed ID: 7847320
[No Abstract] [Full Text] [Related]
14. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
Eissele R; Brunner G; Simon B; Solcia E; Arnold R
Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell-cycle related proteins in Helicobacter pylori gastritis and association with gastric carcinoma.
Polat A; Cinel L; Dusmez D; Aydin O; Egilmez R
Neoplasma; 2002; 49(2):95-100. PubMed ID: 12088113
[TBL] [Abstract][Full Text] [Related]
16. Fundic gland polyps are not induced by proton pump inhibitor therapy.
Vieth M; Stolte M
Am J Clin Pathol; 2001 Nov; 116(5):716-20. PubMed ID: 11710689
[TBL] [Abstract][Full Text] [Related]
17. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic yield of various tests for Helicobacter pylori infection in patients on acid-reducing drugs.
Yakoob J; Jafri W; Abbas Z; Abid S; Islam M; Ahmed Z
Dig Dis Sci; 2008 Jan; 53(1):95-100. PubMed ID: 17497222
[TBL] [Abstract][Full Text] [Related]
19. Nodular gastritis in adults: clinical features, endoscopic appearance, histopathological features, and response to therapy.
Dwivedi M; Misra SP; Misra V
J Gastroenterol Hepatol; 2008 Jun; 23(6):943-7. PubMed ID: 17614956
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori-negative gastritis: prevalence and risk factors.
Nordenstedt H; Graham DY; Kramer JR; Rugge M; Verstovsek G; Fitzgerald S; Alsarraj A; Shaib Y; Velez ME; Abraham N; Anand B; Cole R; El-Serag HB
Am J Gastroenterol; 2013 Jan; 108(1):65-71. PubMed ID: 23147524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
